NCT06251544 2026-03-04
TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer
Baylor College of Medicine
Phase 1 Not yet recruiting
Baylor College of Medicine
Delphinus Medical Technologies, Inc.
Delphinus Medical Technologies, Inc.